Metabolomics as a Challenging Approach for Medicinal Chemistry and Personalized Medicine

被引:55
|
作者
Frederich, Michel [1 ]
Pirotte, Bernard [2 ]
Fillet, Marianne [3 ]
de Tullio, Pascal [2 ]
机构
[1] Univ Liege, CIRM, Lab Pharmacognosy, Quartier Hop, Ave Hippocrate 15, B-4000 Liege, Belgium
[2] Univ Liege, CIRM, Med Chem Lab, Quartier Hop, Ave Hippocrate 15, B-4000 Liege, Belgium
[3] Univ Liege, CIRM, Lab Anal Med, Quartier Hop, Ave Hippocrate 15, B-4000 Liege, Belgium
关键词
NUCLEAR-MAGNETIC-RESONANCE; TISSUE EXTRACTION PROTOCOL; EXHALED BREATH CONDENSATE; 2 DISTINCT PHENOTYPES; NMR-SPECTROSCOPY; MASS-SPECTROMETRY; SYSTEMS BIOLOGY; DRUG DISCOVERY; IN-VIVO; METABONOMIC IDENTIFICATION;
D O I
10.1021/acs.jmedchem.5b01335
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
"Omics" sciences have been developed to provide a holistic point of view of biology and to better understand the complexity of an organism as a whole. These systems biology approaches can be examined at different levels, starting from the most fundamental, i.e., the genome, finishing with the most functional, i.e., the metabolome. Similar to how genomics applied to the exploration of DNA, metabolomics is the qualitative and quantitative study of metabolites. This emerging field is clearly linked to genomics, transcriptomics, and proteomics: In addition, metabdlomics provides a unique and direct vision of the functional outcome of an organism's activities that are. required for it to survive, grow, and respond to internal and external stimuli or stress, e.g., pathologies and drugs. The links between metabolic changes, patient phenotype, physiological and/or pathological status, and treatment are now well established and have opened a new area for the application of metabolomics in the drug discovery process and in personalized medicine.
引用
收藏
页码:8649 / 8666
页数:18
相关论文
共 50 条
  • [21] Will "personalized medicine" need personalized laboratory approach?
    Guidi, Gian Cesare
    Lippi, Giuseppe
    CLINICA CHIMICA ACTA, 2009, 400 (1-2) : 25 - 29
  • [22] The patentability of medicinal inventions related to personalized medicine in Japan
    Itsuki Shimbo
    Andrew Cobden
    Koichi Sumikura
    Nature Biotechnology, 2005, 23 : 1367 - 1369
  • [23] The patentability of medicinal inventions related to personalized medicine in Japan
    Shimbo, I
    Cobden, A
    Sumikura, K
    NATURE BIOTECHNOLOGY, 2005, 23 (11) : 1367 - 1369
  • [24] Metabolomics as a robust tool in systems biology and personalized medicine: an open letter to the metabolomics community
    Michael Snyder
    Xiyan Li
    Metabolomics, 2013, 9 : 532 - 534
  • [25] Metabolomics as a robust tool in systems biology and personalized medicine: an open letter to the metabolomics community
    Snyder, Michael
    Li, Xiyan
    METABOLOMICS, 2013, 9 (03) : 532 - 534
  • [26] Evolution of a thienopyrimidine antitubercular relying on medicinal chemistry and metabolomics insights
    Li, Shao-Gang
    Vilcheze, Catherine
    Chakraborty, Sumit
    Wang, Xin
    Kim, Hiyun
    Anisetti, Monica
    Ekins, Sean
    Rhee, Kyu Y.
    Jacobs, William R., Jr.
    Freundlich, Joel S.
    TETRAHEDRON LETTERS, 2015, 56 (23) : 3246 - 3250
  • [27] Challenging course on medicinal chemistry for non-science majors
    Zysmilich, Martin G.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 234
  • [28] Metabolomics and Cardiology: Toward the Path of Perinatal Programming and Personalized Medicine
    Pintus, Roberta
    Bassareo, Pier Paolo
    Dessi, Angelica
    Deidda, Martino
    Mercuro, Giuseppe
    Fanos, Vassilios
    BIOMED RESEARCH INTERNATIONAL, 2017, 2017
  • [29] Novel Applications of Metabolomics in Personalized Medicine: A Mini-Review
    Li, Bingbing
    He, Xuyun
    Jia, Wei
    Li, Houkai
    MOLECULES, 2017, 22 (07):
  • [30] Challenging medicinal chemistry: ups and downs in a drug discovery project
    Peter Nussbaumer
    Monatshefte für Chemie - Chemical Monthly, 2018, 149 : 1191 - 1197